Anna Borodovsky
- Molecular Biology top 1%
- Ubiquitin and proteasome pathways 11
- RNA Interference and Gene Delivery 9
- Advanced biosensing and bioanalysis techniques 4
- Immunology top 2%
- Complement system in diseases 9
- Cancer Research top 2%
- Oncology top 2%
- Peptidase Inhibition and Analysis 6
- Cell Biology top 2%
-
- Renal Diseases and Glomerulopathies 3
-
- Blood Coagulation and Thrombosis Mechanisms 3
-
- Adenosine and Purinergic Signaling 3
- Co-authors
- Hidde L. PloeghBenedikt M. KesslerKeith D. WilkinsonKevin FitzgeraldWilliam QuerbesHuib OvaaMatthias NahrendorfDaniel G. Anderson
- Journals
- Blood (5 papers)Circulation Research (2 papers)The Journal of Experimental Medicine (2 papers)
- Partner nations
- United StatesUnited KingdomDenmark
In The Last Decade
Anna Borodovsky
43 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Molecular Biology 5.0k
- Immunology 1.0k
- Cancer Research 689
- Oncology 1.0k
- Cell Biology 582
Countries citing papers authored by Anna Borodovsky
This map shows the geographic impact of Anna Borodovsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Borodovsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Borodovsky more than expected).
Fields of papers citing papers by Anna Borodovsky
This network shows the impact of papers produced by Anna Borodovsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Borodovsky. The network helps show where Anna Borodovsky may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna Borodovsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 28 | |
| 3 | 2020 | 58 | |
| 4 | 2020 | 17 | |
| 5 | 2019 | 42 | |
| 6 | 2018 | 15 | |
| 7 | 2018 | 32 | |
| 8 | A Highly Durable RNAi Therapeutic Inhibitor of PCSK9breakdown → | 2016 | 586 |
| 9 | 2015 | 148 | |
| 10 | 2013 | 227 | |
| 11 | Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escapebreakdown → | 2013 | 1232 |
| 12 | 2008 | 177 | |
| 13 | 2008 | 61 | |
| 14 | 2003 | 176 | |
| 15 | 2003 | 24 | |
| 16 | 2002 | 29 | |
| 17 | 2002 | 474 | |
| 18 | Multiple Associated Proteins Regulate Proteasome Structure and Functionbreakdown → | 2002 | 506 |
| 19 | 2001 | 410 | |
| 20 | BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppressionbreakdown → | 1998 | 569 |
About Anna Borodovsky
Anna Borodovsky is a scholar working on Transplantation, Immunology, Physiology, Nephrology and Genetics, having authored 43 papers that have together received 6.7k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (11 papers), RNA Interference and Gene Delivery (9 papers), Complement system in diseases (9 papers), Peptidase Inhibition and Analysis (6 papers), Advanced biosensing and bioanalysis techniques (4 papers), Renal Diseases and Glomerulopathies (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Adenosine and Purinergic Signaling (3 papers). The work is most often cited by research in Molecular Biology (5.0k citations), Immunology (1.0k citations), Cancer Research (689 citations), Oncology (1.0k citations) and Cell Biology (582 citations). Anna Borodovsky has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include Hidde L. Ploegh, Benedikt M. Kessler, Keith D. Wilkinson, Kevin Fitzgerald, William Querbes, Huib Ovaa, Matthias Nahrendorf, Daniel G. Anderson, Herman S. Overkleeft and Akin Akinc. Their work appears in journals such as Blood, Circulation Research, The Journal of Experimental Medicine, Molecular Immunology and ChemBioChem.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.